ImmunityBio(DE:26CA)
€5.46-0.18 (-3.19%)
DE:26CA
ImmunityBio ownership
€5.46
At close:-0.18 (-3.19%)
ImmunityBio (26CA) Ownership - Who Owns ImmunityBio?
19 Followers
ImmunityBio (26CA) Ownership Overview
- 61.92% Insiders
- 4.55% Mutual Funds
- 5.24% Other Institutional Investors
- 8.04% ETFs
- 20.25% Public Companies and Individual Investors
The ownership structure of ImmunityBio (DE:26CA) stock is a mix of institutional, retail, and individual investors. Approximately 17.83% of the company’s stock is owned by Institutional Investors, 61.92% is owned by Insiders, and 20.25% is owned by Public Companies and Individual Investors.
The ownership structure of ImmunityBio (DE:26CA) stock is a mix of institutional, retail, and individual investors. Approximately 17.83% of the company’s stock is owned by Institutional Investors, 61.92% is owned by Insiders, and 20.25% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Apr 01, 2026 | Shiong Patrick Soon | $24,967,750 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €83,423 | |
| Dec 31, 2025 | Woodline Partners Lp | €6,824,149 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Shiong Patrick Soon | 654,612,336 | Insider | 61.53% | 3,939,457,038 |
| Vanguard | 37,686,220 | Institution | 3.54% | 226,795,672 |
| BlackRock, Inc. | 36,123,813 | Institution | 3.40% | 217,393,107 |
| Vanguard Index Funds | 28,575,204 | Institution | 2.69% | 171,965,578 |
| Ishares | 22,260,182 | Institution | 2.09% | 133,961,775 |
| Spdr | 13,579,606 | Institution | 1.28% | 81,722,069 |
| Fidelity Salem Street Trust | 4,635,647 | Institution | 0.44% | 27,897,324 |
| Schwab | 3,646,491 | Institution | 0.34% | 21,944,583 |
| Fidelity Concord Street Trust | 3,580,436 | Institution | 0.34% | 21,547,064 |
| Barry J. Simon | 2,777,788 | Insider | 0.26% | 16,716,728 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 28,575,204 | Institution | 2.69% | 171,965,578 |
| Fidelity Salem Street Trust | 4,635,647 | Institution | 0.44% | 27,897,324 |
| Fidelity Concord Street Trust | 3,580,436 | Institution | 0.34% | 21,547,064 |
| Vanguard Scottsdale Funds | 2,669,947 | Institution | 0.25% | 16,067,741 |
| Tiaa-cref Funds | 1,205,269 | Institution | 0.11% | 7,253,309 |
| Schwab Capital Trust | 1,154,289 | Institution | 0.11% | 6,946,511 |
| Vanguard World Fund | 1,095,968 | Institution | 0.10% | 6,595,535 |
| Federated Hermes Mdt Series | 1,081,225 | Institution | 0.10% | 6,506,812 |
| Bridge Builder Trust | 603,065 | Institution | 0.06% | 3,629,245 |
| Wp Trust | 465,000 | Institution | 0.04% | 2,798,370 |
FAQ
Who Owns ImmunityBio (DE:26CA)?
According to the latest TipRanks data, approximately 17.83% of the company's stock is held by institutional investors, 61.92% is held by insiders, and 20.25% is held by public companies and individual investors.
What percentage of ImmunityBio (DE:26CA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 17.83% of ImmunityBio (DE:26CA) stock is held by institutional investors: 4.55% by mutual funds, 8.04% by ETFs and 5.24% by other institutional investors.
What percentage of ImmunityBio (DE:26CA) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.25% of ImmunityBio (DE:26CA) stock is held by public companies and individual investors.
Who owns the most shares of ImmunityBio (DE:26CA)?
Shiong Patrick Soon owns the most shares of ImmunityBio (DE:26CA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
